George Bracher, MD
Gastroenterology · Chandler, AZNPI 1669444006
Payments from drug & device makers
Across 80 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$645
- Bristol Myers Squibb$156
- Gilead$155
- Shionogi Inc$83
- Johnson & Johnson$74
- Takeda Pharmaceuticals U.S.A., Inc.$65
- plus $374 from 13 others
What the payments were for
- Food & beverage$1,51798%
- Education$362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $645 |
| Bristol Myers Squibb | 10 | $156 |
| Gilead | 9 | $155 |
| Shionogi Inc | 5 | $83 |
| Johnson & Johnson | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Intuitive Surgical | 1 | $52 |
| Pfizer | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Coloplast | 1 | $36 |
| Medtronic | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 2 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Apollo Endosurgery US Inc | 1 | $23 |
| Shire North American Group Inc | 1 | $17 |
| Organon | 1 | $14 |
| Braintree Laboratories, Inc. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $11 |
How this compares
$1,553 in reported general payments places this provider in the 30th percentile of 355 gastroenterology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 394 | $5,648 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 25 | $1,560 |
| Colestipol Hcl | 16 | $1,169 |
| Famotidine | 87 | $1,020 |
| Omeprazole | 44 | $993 |
| LoperamideLoperamide Hcl | 12 | $638 |
| Sucralfate | 13 | $450 |
| Dicyclomine Hcl | 26 | $397 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Chandler
- Joseph DavisChandler$7.4M
- Sanjay AhluwaliaChandler$104K
- Sajiv SethiChandler$65K
- Tarun MullickChandler$61K
- Sam MoussaTucson$3.9M
- Manreet KaurScottsdale$2.5M
- Bassel KissoTucson$2.3M
- Fadi DeebTucson$1.5M
- Chirag TrivediSun City$954K
- Joel BrillParadise Valley$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.